Dabur India Ltd Q1 FY2025 Concall Summary

Key Takeaways

• Rural recovery leads, urban GT lags: Dabur calls itself the rural bellwether and reports three quarters of recovery, one quarter ahead of the broader FMCG market, while general trade wholesale remains the urban drag.
• Gross margin up 120 bps, mostly reinvested: Moderation in input inflation and cost-saving programs expanded gross margin, but roughly 80% of the gain was plowed back into media spend, with the balance flowing to operating margin.
• Nectar squeezed by cola price war: A third cola entrant dropped prices, widening nectar's relative price index from 2.2x to 3.25x versus cola; acute summer heat then shifted consumer preference from nourishment to thirst-quenching, a dual headwind Dabur has not structurally answered.
• International constant-currency growth strong at 18.4%, but currency devaluations in Egypt, Nigeria and Turkey eroded INR performance, and management expects the overlap to take one to two more quarters before easing.
• What to watch next quarter: Whether the monsoon-driven rural sentiment uptick converts to sustained volume growth, how the Oral Care RGM study's action points affect market share, and whether nectar can hold share as cola competition persists.

Rural & Urban Demand

• Rural lead indicator: Dabur's rural recovery has run for three quarters, one quarter ahead of the broader FMCG market; management attributes it to lower inflation, elasticity working, roughly 2% deflation, a good harvest, normal monsoon, higher MGNREGA outlay and new government schemes.
• Sub-stockist channel healing: Money is returning to the channel, credit terms are normalizing and inventory levels are coming down, all pointing to improving rural sentiment.
• Urban split-screen: E-commerce grew 30% and quick commerce surged 70%, now making up 30 to 35% of e-commerce; modern trade grew roughly 15%, led by Reliance and D Mart. General trade wholesale is the drag, and Dabur is converting indirect outlets to direct, adding 50,000 outlets to its direct reach.
• Subsequent-quarter optimism: Management expects the next quarter to be better than previous quarters for the FMCG sector, though it cautions that improving sentiment still needs to be watched before calling it a durable trend.

Mohit Malhotra: "Dabur is the bellwether for the rural performance, which we think we are. For past 3 quarters, we have seen our rural recovery happen whereas the FMCG market is showing rural recovery for the past 2 quarters. So we are the lead indicators."

Category & Brand Performance

Health Care

• Digestives up 11%, Health supplements up 7%: Dabur Glucose surged over 30% on harsh summer demand and gained 70 bps of market share; value-added Glucose variants with Vitamin C and flavors are margin-accretive. Shilajit and Honitus were impacted by the same harsh summers.
• Chyawanprash hit by heatwave: The severe summer made the product a poor consumer fit; a post-monsoon campaign launched in July delivered 8 to 9% growth, and management expects a La Nina-driven severe winter to support the brand going forward.
• Honey faced a one-off crystallization issue in acute winter, requiring stock to be taken back, which suppressed growth.
• OTC & Ethicals muted: Honitus faced a high base from 30%+ growth last year and limited cough/cold incidence in the severe summer. Pudin Hara liquid grew roughly 20%, and Baby Care grew 45% driven by e-commerce and the therapeutic business.

HPC (Hair Care, Oral Care, Skin Care)

• Shampoo and post-wash up 14% driven by the Vatika franchise; coconut oil up 20% with both coconut and perfumed oils growing ahead of category. The Cool King franchise (Toofani Thanda cooling oil and Cool Talc) was launched and well received.
• Oral Care strategy delivering: Dabur Red franchise up 12%, Meswak up 18%; the three-tier strategy of power brand Dabur Red, economy brand Babool and premium Meswak is playing out. Dabur oral care now reaches one in every two households. An inventory correction of roughly INR10 to 11 crores occurred in Oral Care, mostly in the general trade channel, as secondary sales ran ahead of primary.
• Hair oil competitive intensity picked up: Bajaj turned aggressive in coconut oil, dropping prices and squeezing category margins. Sarson Amla underperformed because softening sarson prices widened the price premium from unbranded to branded, and competitors corrected prices to gain share. Dabur's strategy is to stay represented in all subsegments, premiumize, and potentially enter missing subsegments via inorganic routes.
• Skin Care: Gulabari grew double-digit, and new body washes under the brand were well received.

Mohit Malhotra: "competitive intensity in nutshell has picked up. Dabur strategy of representing ourselves in all subsegments of hair oil stays and premiumization will also happen. There are some subsegments where we are not present, which we may want to get presence by way of, if not organic through inorganic route also."

Foods & Beverages

• Foods up 21%, Badshah up 15% YoY: The drinks portfolio grew double-digit, and Dabur exceeded category growth in the J&N segment by 330 bps. Badshah faced pushback from international regulators, especially in the UK, where screening and scrutiny of dispatches from India tightened following a controversy.
• Nectar under dual pressure: A third cola entrant dropped cola prices, widening nectar's relative price index from 2.2x to 3.25x. Simultaneously, acute summer heat of 40 to 50 degrees Celsius shifted consumer preference toward hydration and refreshment over nourishment and health. In-home nectar consumption stayed put while out-of-home declined, though the drink and Fizz portfolio significantly improved out-of-home performance. Dabur gained 332 bps market share in nectar despite muted category growth.
• Hajmola pivoted to drinks: Hajmola Zeera launched in the drink segment and is doing exceedingly well, opening a very large TAM. Fizz capacity is being ramped up in Jammu alongside capacity for drinks and coconut water.
• Coconut water investment: An aseptic line has been ordered; next season coconut water will be available in a PET bottle, addressing the market share loss to Storia that occurred when only Tetra Pak was available.

Mohit Malhotra: "The price index between a nectar and cola has significantly increased. Our relative price index used to be 2.2x. This 2.2x has gone up to around 3.2 to 3.25x."

Home Care

• Odonil grew high single-digits in aerosol and gel formats; Odomos liquid vapourizer was introduced and performed well; Sanifresh grew double-digit on strong execution.
• INR1,000 crore ambition: Total Home Care currently stands at roughly INR800 crores, with Odomos alone around INR800-odd crores; management wants to reach INR1,000 crores by expanding the TAM.

Mohit Malhotra: "We want to take our Home Care to INR1,000 crores... Odomos totally for us should be around INR800-odd crores. So total Home Care will be around INR800 crores. So we should be able to take this up to INR1,000 crores by increasing the TAM."

Competitive Dynamics & Market Share

• Oral Care share shift: The market leader is losing share in the non-herbal segment while herbal players including Patanjali and Dabur are inching up volume market share; attrition is flowing from non-herbal to herbal. An RGM study completed with a major consultant is now being implemented, and management says it will not lose any pricing opportunity versus competitors.
• Nectar vs cola structural gap: Management described the saliency of nectar at over 70% within the subsegment and outlined capacity ramp-up plans, but did not directly address how it will structurally counter the widened price premium versus cola, which does not appear to be going away soon.

Mohit Malhotra: "Ayurveda has got the capability and I think the technical know-how, which the market leader may not have, which is where our unique selling proposition cut ice with the consumer."

Margins & Investment

• Gross margin expanded 120 bps driven by moderating input inflation and cost-saving initiatives including the Samriddhi program, pack price architecture corrections and the RGM study.
• Roughly 80% of the gross margin gain was reinvested into media spend; media as a percentage of top line was 8% and management wants to inch it higher. The balance flowed to operating margin.
• Deflationary environment expected in Q2, but Q3 and Q4 may see inflation return; management will watch gross margins and media spend dynamically. Margins will grow beyond 19.6% but no specific quantum was committed.
• Price increase profile: Health care took a 6% price increase in the current quarter; HPC carries a price element of roughly 1.4 to 1.5%; Foods is all volume-driven, though some price increases may be taken if food inflation continues. Volume growth is expected to rise while price growth stays muted at around 2%.

International Business

• Constant-currency growth of 18.4% was strong, but currency devaluations in Egypt, Nigeria and Turkey eroded INR performance.
• Currency headwind trajectory: Devaluation has hovered around 3% for the last two to three quarters; management expects one to two more quarters before the base effect overlaps, with the impact starting to reduce by Q3 though not completely eliminated.
• Badshah regulatory friction: International regulators, especially in the UK, tightened screening and scrutiny of dispatches from India following a controversy, creating a pushback for Badshah's international business.

Guidance & Commitments

Key Metrics